Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma
暂无分享，去创建一个
S. Groshen | J. Friedberg | K. Venkatakrishnan | D. Mahadevan | M. Schmelz | K. McDonagh | A. Vanderwalde | J. Ruan | D. Persky | S. Iyer | S. Bernstein | P. Rosen | S. Weitman | K. Kelly | Xiaofei Zhou | E. Sheldon-Waniga | R. Mena | Steven I. Park | A. Karnad | G. Monohan | S. Puvvada | A. Stefanovic | E. Leonard | J. Hayslip | C. Spier